BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/5/2024 10:11:20 AM | Browse: 374 | Download: 887
Publication Name World Journal of Clinical Cases
Manuscript ID 91378
Country Greece
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, General & Internal
Manuscript Type Editorial
Article Title Bringing gut microbiota into the spotlight of clinical research and medical practice
Manuscript Source Invited Manuscript
All Author List Efstathia Davoutis, Zoi Gkiafi and Panagis M Lykoudis
ORCID
Author(s) ORCID Number
Efstathia Davoutis http://orcid.org/0009-0009-9241-4051
Zoi Gkiafi http://orcid.org/0009-0007-8335-3889
Panagis M Lykoudis http://orcid.org/0000-0003-2170-0471
Funding Agency and Grant Number
Corresponding Author Panagis M Lykoudis, MD, MSc, PhD, Lecturer, Division of Surgery and Interventional Science, University College London, Gower Street, London WC1E 6BT, United Kingdom. p.lykoudis@ucl.ac.uk
Key Words Gut microbiota; Biomarker; Fecal microbiota transplantation; Dysbiosis; Prebiotics
Core Tip Gut microbiota (GM) serves as a multifaceted tool in healthcare, acting as a potential biomarker, diagnostic, prognostic, and therapeutic entity. While dysbiosis is linked to various diseases, harnessing microbiome's diagnostic potential introduces challenges due to its variability and complex identification techniques. As a prognostic tool, GM provides insights into an individual's health status and disease risks, influencing treatment outcomes. Moreover, it emerges as a therapeutic pathway, with interventions such as prebiotics and fecal microbiota transplantation showing promise. Despite growing recognition, its integration into clinical practice remains limited, necessitating increased research, educational initiatives, and collaborations, to unlock the full potential of GM in advancing patient care.
Publish Date 2024-05-05 10:11
Citation Davoutis E, Gkiafi Z, Lykoudis PM. Bringing gut microbiota into the spotlight of clinical research and medical practice. World J Clin Cases 2024; 12(14): 2293-2300
URL https://www.wjgnet.com/2307-8960/full/v12/i14/2293.htm
DOI https://dx.doi.org/10.12998/wjcc.v12.i14.2293
Full Article (PDF) WJCC-12-2293-with-cover.pdf